Boston Scientific to acquire Preventice Solutions for up to $1.225 billion

Boston Scientific has entered into a definitive agreement to acquire Preventice Solutions, a provider of mobile cardiac health solutions, for an upfront cash payment of $925 million and up to $300 million in potential milestone payments. Boston Scientific already holds a 22% stake.

“Boston Scientific today announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc.”news.bostonscientific.com

• 5 sources
• news.bostonscientific.comBoston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.Jan 21, 2021
• news.bloomberglaw.comBoston Scientific to Buy Preventice for Up to $1.2 BillionEric PfannerJan 21, 2021
• prnewswire.comBoston Scientific Announces Agreement To Acquire Lumenis LTD. Surgical Business From Baring Private Equity AsiaBoston Scientific CorporationMar 3, 2021
• financialpost.comBoston Scientific to buy surgical business of Lumenis for $1.07 billionMar 3, 2021
• w.theasset.comBPEA to sell Lumenis Surgical to Boston Scientific for US$1.07 billion | The Asset

Summarized from public sources; check the original articles before acting on it.